Position in MRK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$6,756,569
+$1,261,892 QoQ
Shares Held
56,169
+7.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. MRK ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,756,569 | 56,169 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,494,677 | 52,201 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,030,486 | 48,022 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,719,411 | 46,986 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $4,903,229 | 54,626 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $5,861,859 | 58,925 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,777,033 | 59,678 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,524,935 | 60,783 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,723,693 | 58,535 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,847,723 | 53,639 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,576,698 | 54,169 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $6,480,417 | 56,161 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $5,903,687 | 55,491 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $5,824,320 | 52,495 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,240,979 | 49,245 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,647,073 | 40,003 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,135,540 | 38,215 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,865,722 | 37,392 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,103,920 | 41,325 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,975,013 | 38,254 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,345,772 | 30,429 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,613,590 | 31,951 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,038,459 | 36,630 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,881,317 | 37,260 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,638,810 | 34,297 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||